Mol2Med™ First-Time-Right 3-STEP Approach
Crystal Pharmatech are a specialized CRO/CDMO focused on Solid State Research, Pre-Formulation, contract research manufacturing organization. Our strength is our focus and expertise in these specialties and the outcome for the client is the following Mol2Med™ Integrated Services: First-Time-Right 3-STEP Approach, designed to expedite small molecule lead compounds or preclinical candidates into Phase I and beyond, with unparalleled efficiency and precision.
Highlights of API Form and Solid-State Services
Serving over 1000 clients worldwide
Supported solid form screening, crystallization, and preclinical formulation development of over 2,000 new drug molecules
The world's leading technology supports the understandingof molecule and formulation with a high-end platform
High-quality service, a culture of confidentiality, and fast turnaround with cost-effective pricing
Customized solution for your molecule, spanning the entire drug lifecycle
For more information about crystallization toll manufacturing, please feel free to contact us!
As a professional cdmo pharma company, crystal biotech trys our best to provide good products and service for you.
Sign in to leave a comment.